1.
E. Akaho. Development of Cyclic Tetrapeptide as an EGFR Tyrosine Kinase Inhibitor Assayed by ELISA Experiment and Docking Study: A Novel Approach. CAPR-V2 [Internet]. 2022 Apr. 21 [cited 2026 Jun. 4];:108-21. Available from: https://stm.bookpi.org/CAPR-V2/article/view/6582